These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3167488)

  • 1. Imipramine versus phenelzine in melancholias and dysthymic disorders.
    Campbell MJ
    Br J Psychiatry; 1988 Jun; 152():862-3. PubMed ID: 3167488
    [No Abstract]   [Full Text] [Related]  

  • 2. Double-blind study of imipramine versus phenelzine in Melancholias and Dysthymic Disorders.
    Vallejo J; Gasto C; Catalan R; Salamero M
    Br J Psychiatry; 1987 Nov; 151():639-42. PubMed ID: 3446308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenelzine versus imipramine for atypical depression.
    Nakdimen KA
    Am J Psychiatry; 1988 Oct; 145(10):1322. PubMed ID: 3421370
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of treatment on the melancholias (depressions).
    Hamilton M
    Br J Psychiatry; 1982 Mar; 140():223-30. PubMed ID: 7093590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of imipramine and phenelzine on plasma PEA levels.
    McGrath PJ; Cooper TB; Quitkin FM; Klein DF
    Psychiatry Res; 1988 Nov; 26(2):239. PubMed ID: 3237916
    [No Abstract]   [Full Text] [Related]  

  • 6. Phenelzine versus imipramine in the treatment of probable atypical depression: defining syndrome boundaries of selective MAOI responders.
    Quitkin FM; Stewart JW; McGrath PJ; Liebowitz MR; Harrison WM; Tricamo E; Klein DF; Rabkin JG; Markowitz JS; Wager SG
    Am J Psychiatry; 1988 Mar; 145(3):306-11. PubMed ID: 3278631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relevance of DMS-III depressive subtype and chronicity of antidepressant efficacy in atypical depression. Differential response to phenelzine, imipramine, and placebo.
    Stewart JW; McGrath PJ; Quitkin FM; Harrison W; Markowitz J; Wager S; Leibowitz MR
    Arch Gen Psychiatry; 1989 Dec; 46(12):1080-7. PubMed ID: 2686575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of phenelzine and imipramine in depressed inpatients.
    Davidson JR; McLeod MN; Turnbull CD; Miller RD
    J Clin Psychiatry; 1981 Oct; 42(10):395-7. PubMed ID: 7026542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An outpatient evaluation of phenelzine and imipramine.
    Davidson J; Raft D; Pelton S
    J Clin Psychiatry; 1987 Apr; 48(4):143-6. PubMed ID: 3549705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical depression, panic attacks, and response to imipramine and phenelzine. A replication.
    Quitkin FM; McGrath PJ; Stewart JW; Harrison W; Tricamo E; Wager SG; Ocepek-Welikson K; Nunes E; Rabkin JG; Klein DF
    Arch Gen Psychiatry; 1990 Oct; 47(10):935-41. PubMed ID: 2222132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How blind is blind? Assessment of patient and doctor medication guesses in a placebo-controlled trial of imipramine and phenelzine.
    Rabkin JG; Markowitz JS; Stewart J; McGrath P; Harrison W; Quitkin FM; Klein DF
    Psychiatry Res; 1986 Sep; 19(1):75-86. PubMed ID: 3538107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenelzine and imipramine in mood reactive depressives. Further delineation of the syndrome of atypical depression.
    Quitkin FM; McGrath PJ; Stewart JW; Harrison W; Wager SG; Nunes E; Rabkin JG; Tricamo E; Markowitz J; Klein DF
    Arch Gen Psychiatry; 1989 Sep; 46(9):787-93. PubMed ID: 2673130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to phenelzine and imipramine in placebo nonresponders with atypical depression. A new application of the crossover design.
    Quitkin FM; Harrison W; Stewart JW; McGrath PJ; Tricamo E; Ocepek-Welikson K; Rabkin JG; Wager SG; Nunes E; Klein DF
    Arch Gen Psychiatry; 1991 Apr; 48(4):319-23. PubMed ID: 2009033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet imipramine binding in patients with posttraumatic stress disorder before and after phenelzine treatment.
    Weizman R; Laor N; Schujovitsky A; Wolmer L; Abramovitz-Schnaider P; Freudstein-Dan A; Rehavi M
    Psychiatry Res; 1996 Jul; 63(2-3):143-50. PubMed ID: 8878310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic depression: response to placebo, imipramine, and phenelzine.
    Stewart JW; McGrath PJ; Quitkin FM; Rabkin JG; Harrison W; Wager S; Nunes E; Ocepek-Welikson K; Tricamo E
    J Clin Psychopharmacol; 1993 Dec; 13(6):391-6. PubMed ID: 8120152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind crossover trial of imipramine and phenelzine for outpatients with treatment-refractory depression.
    McGrath PJ; Stewart JW; Nunes EV; Ocepek-Welikson K; Rabkin JG; Quitkin FM; Klein DF
    Am J Psychiatry; 1993 Jan; 150(1):118-23. PubMed ID: 8417553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of tricyclic refractory depression with a monoamine oxidase inhibitor antidepressant.
    McGrath PJ; Stewart JW; Harrison W; Quitkin FM
    Psychopharmacol Bull; 1987; 23(1):169-72. PubMed ID: 3602314
    [No Abstract]   [Full Text] [Related]  

  • 18. Factors associated with premature medication discontinuation among responders to an MAOI or a tricyclic antidepressant.
    Agosti V; Stewart JW; Quitkin FM; Rabkin JG; McGrath PJ; Markowitz J
    J Clin Psychiatry; 1988 May; 49(5):196-8. PubMed ID: 3366755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic efficacy of phenelzine and imipramine in chronic atypical depression: likelihood of recurrence on discontinuation after 6 months' remission.
    Stewart JW; Tricamo E; McGrath PJ; Quitkin FM
    Am J Psychiatry; 1997 Jan; 154(1):31-6. PubMed ID: 8988955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Social functioning in chronic depression: effect of 6 weeks of antidepressant treatment.
    Stewart JW; Quitkin FM; McGrath PJ; Rabkin JG; Markowitz JS; Tricamo E; Klein DF
    Psychiatry Res; 1988 Aug; 25(2):213-22. PubMed ID: 3051072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.